Determination of bovine lactoferrin in lactoferrin-supplemented dairy products and raw milk by an automated latex assay

被引:8
作者
Soejima, Takashi
Yamauchi, Koji
Yamamoto, Tomoko
Ohara, Yasuko
Nagao, Eiji
Kanbara, Keiichi
Fujisawa, Munetoshi
Okuda, Yuko
Namba, Shyunji
机构
[1] Morinaga Milk Ind Co Ltd, Analyt Res Ctr, Kanagawa 2288583, Japan
[2] Morinaga Milk Ind Co Ltd, Nutr Sci Lab, Kanagawa 2288583, Japan
[3] Bio Links Co Ltd, Tuzuki Ltd, Yokohama, Kanagawa 2240065, Japan
[4] Toho Univ, Ohmori Hosp, Dept Lab Med, Ohta Ku, Tokyo 1438541, Japan
关键词
automated latex assay; bovine lactoferrin; dairy products; determination; ICH; latex agglutination; validation;
D O I
10.1017/S0022029906002081
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Latex immune agglutination method with a multipurpose auto-analyser (the automated latex assay) was validated for determination of bovine lactoferrin (BLF) in various dairy products. Reproducibility-within-laboratory (intermediate precision) due to day for infant formula, UHT milk and yogurt supplemented with BLF at 50 mg/100 g for infant formula and UHT milk, and at 100mg/100g for yogurt were 1.62 to 3.10mg/100g. Reproducibility-within-laboratory due to analysis (morning, noon, and evening) for raw milk was 1.59 mg/100 g. Trueness, accuracy in determining known amounts added for BLF-supplemented dairy products was -4.7 to -2.0 mg/100 g. BLF concentration in raw milks was 20.3 to 21.8 mg/100 g. Although interference by the matrixes took place in infant formula and raw milk, BLF assays were accurately carried out by 2000-fold dilution or standard-addition method. Automated latex assay for BLF is simple, rapid, precise and accurate enough for a routine method in various dairy products containing BLF.
引用
收藏
页码:100 / 105
页数:6
相关论文
共 11 条
[1]  
BASS R, 1996, CONSENSUS GUIDELINE
[2]  
Chen PW, 2004, J FOOD DRUG ANAL, V12, P133
[3]   Determination of lactoferrin in bovine milk, colostrum and infant formulas by optical biosensor analysis [J].
Indyk, HE ;
Filonzi, EL .
INTERNATIONAL DAIRY JOURNAL, 2005, 15 (05) :429-438
[4]  
Moore LL, 2003, EPIDEMIOLOGY, V14, P200
[5]  
NAMBA S, 2002, JAPANESE J MED PHARM, V48, P869
[6]   Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats [J].
Sekine, K ;
Watanabe, E ;
Nakamura, J ;
Takasuka, N ;
Kim, DJ ;
Asamoto, M ;
Krutovskikh, V ;
BabaToriyama, H ;
Ota, T ;
Moore, MA ;
Masuda, M ;
Sugimoto, H ;
Nishino, H ;
Kakizoe, T ;
Tsuda, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (06) :523-526
[7]   Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study [J].
Tanaka, K ;
Ikeda, M ;
Nozaki, A ;
Kato, N ;
Tsuda, H ;
Saito, S ;
Sekihara, H .
JAPANESE JOURNAL OF CANCER RESEARCH, 1999, 90 (04) :367-371
[8]   THE BACTERIOSTATIC EFFECTS OF ORALLY-ADMINISTERED BOVINE LACTOFERRIN ON INTESTINAL ENTEROBACTERIACEAE OF SPF MICE FED BOVINE-MILK [J].
TERAGUCHI, S ;
OZAWA, K ;
YASUDA, S ;
SHIN, K ;
FUKUWATARI, Y ;
SHIMAMURA, S .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1994, 58 (03) :482-487
[9]   Bovine lactoferrin and lactoferricin derived from milk: production and applications [J].
Tomita, M ;
Wakabayashi, H ;
Yamauchi, K ;
Teraguchi, S ;
Hayasawa, H .
BIOCHEMISTRY AND CELL BIOLOGY, 2002, 80 (01) :109-112
[10]  
Yamauchi K, 2000, MYCOSES, V43, P197, DOI 10.1046/j.1439-0507.2000.00571.x